Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Dyspnoea, Lethargy, Malaise, Product dose omission issue
Clinical narrative: Consumer never her 2nd dose of the vaccine.; allergic reaction to the vaccine; Shortness of breath / minor breathing issue; 6 hours later I got hives; she had some lethargic issues after the vaccine/felt crummy for couple of days; Feeling unwell/felt crummy for couple of days; level of intense itching 15 to 20 minutes after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (allergic reaction to the vaccine), DYSPNOEA (Shortness of breath / minor breathing issue), URTICARIA (6 hours later I got hives), LETHARGY (she had some lethargic issues after the vaccine/felt crummy for couple of days) and MALAISE (Feeling unwell/felt crummy for couple of days) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: DOXYCYCLINE HYDROCHLORIDE (doxycycline almost killed her before). Concurrent medical conditions included Allergy (allergies to multiple products).    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced ALLERGY TO VACCINE (allergic reaction to the vaccine), DYSPNOEA (Shortness of breath / minor breathing issue), URTICARIA (6 hours later I got hives), LETHARGY (she had some lethargic issues after the vaccine/felt crummy for couple of days), MALAISE (Feeling unwell/felt crummy for couple of days) and VACCINATION SITE PRURITUS (level of intense itching 15 to 20 minutes after vaccination). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Consumer never her 2nd dose of the vaccine.). The patient was treated with ACRIVASTINE (BENADRYL [ACRIVASTINE]) for Adverse event, at an unspecified dose and frequency. On 26-Jan-2021, URTICARIA (6 hours later I got hives) had resolved. At the time of the report, ALLERGY TO VACCINE (allergic reaction to the vaccine), DYSPNOEA (Shortness of breath / minor breathing issue), LETHARGY (she had some lethargic issues after the vaccine/felt crummy for couple of days), MALAISE (Feeling unwell/felt crummy for couple of days) and VACCINATION SITE PRURITUS (level of intense itching 15 to 20 minutes after vaccination) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Consumer never her 2nd dose of the vaccine.) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products reported. Consumer states that she had level of intense itching 15 to 20 minutes after vaccination. Consumer states 4 hours later she had minor breathing issue and shortness of breath. Consumer states 6 hours late she got hives.